Berberine-mediated blockade of HMGB1/receptor for advanced glycation end products signaling reduces the expression of TNF-α, IL-1α, and complement C1q A chain in the hippocampus of CLP mice, inhibits the activation of microglia, and thus alleviates sepsis-induced cognitive impairment7. The gene discussed is TNF; the disease is Sepsis.